Foldrx Pharmaceuticals

📍 United States👥 6 employees💰 Last funded Jun 2010
Pharmaceuticals🌐 foldrx.com
Website LinkedIn
FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The folding and maintenance of proteins in a correctly folded active form is essential to normal cellular function.Accumulation of misfolded proteins, due to mutations or to defects in cellular quality control mechanisms, can prevent them from performing their normal function or result in toxic intermediates.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Foldrx Pharmaceuticals?
Foldrx Pharmaceuticals has 1 investors on record on gritt.io.
When did Foldrx Pharmaceuticals last raise funding?
The most recent investment in Foldrx Pharmaceuticals recorded on gritt.io was in June 2010.
What industry is Foldrx Pharmaceuticals in?
Foldrx Pharmaceuticals operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Foldrx Pharmaceuticals based?
Foldrx Pharmaceuticals is headquartered in United States.